Loading...
Subclones dominate at MDS progression following allogeneic hematopoietic cell transplant
Allogeneic hematopoietic cell transplantation (alloHCT) is a potentially curative treatment for myelodysplastic syndromes (MDS), but patients who relapse after transplant have poor outcomes. In order to understand the contribution of tumor clonal evolution to disease progression,we applied exome and...
Na minha lista:
| Udgivet i: | JCI Insight |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Clinical Investigation
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5922277/ https://ncbi.nlm.nih.gov/pubmed/29515031 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.98962 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|